French Registry of CMR Late Gadolinium Enhancement in Myocarditis

NCT07394543 — Not yet recruiting, 5000 participants, Assistance Publique - Hôpitaux de Paris

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

Retrospective French Registry of Cardiovascular Magnetic Resonance Late Gadolinium Enhancement in Patients With Myocarditis

Registry	NCT07394543, acronym MYOCARDITI-LGE
Status	Not yet recruiting
Study type	Observational
Enrollment	5000 (Estimated)
Sponsor	Assistance Publique - Hôpitaux de Paris (Other)
Conditions	Myocarditis Acute
Dates	start 2026-02-10 (estimated), primary completion 2036-02-10 (estimated), completion 2036-02-10 (estimated), first posted 2026-02-06, last updated 2026-02-06

-Summary

Acute myocarditis is a major cause of death in young adults and carries substantial morbidity, including a significant risk of progression to dilated cardiomyopathy. Current diagnostic and therapeutic strategies remain poorly defined, making risk stratification crucial to enable personalized treatments and reduce mortality and major cardiovascular events.

Expand all sections · Collapse all

+Outcome measures

Primary outcomes

All-cause mortality [From enrollment to the end of follow up at 10 years]: All-cause mortality defined using the French national registry of death (INSEE).

Secondary outcomes

All-cause death [From enrollment to the end of follow up at 10 years]
Heart transplantation [From enrollment to the end of follow up at 10 years]
Ventricular arrhythmia [From enrollment to the end of follow up at 10 years]
Hospitalisation for acute heart failure [From enrollment to the end of follow up at 10 years]

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

1. Age ≥ 18 years
2. Ability to provide informed non-opposition
3. AM diagnosis confirmed using CMR, fulfilling the modified Lake Louise diagnostic criteria

Exclusion Criteria:

1\. Patients unable to provide informed non-opposition.

My Notes

Public

To Read Reading Read